What is AbbVie's revenue?

AbbVie (ABBV) generated $62.8B in revenue over the trailing twelve months, up 9.5% year over year.

Is AbbVie profitable?

AbbVie reported $3.6B in net income over the trailing twelve months, a 5.8% net margin.

What are AbbVie's profit margins?

Gross margin is 70.7% and operating margin is 24.4%, with a 5.8% net margin.

What is AbbVie's earnings per share?

AbbVie's diluted EPS over the trailing twelve months is $2.03.

Where does AbbVie's income statement data come from?

Every line is extracted from AbbVie's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

AbbVie ABBV Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$15B+12.4%	$16.62B+10.0%	$15.78B+9.1%	$15.42B+6.6%	$13.34B+8.4%
Total cost of revenue	$4.22B+5.4%	$4.55B+3.5%	$5.3B+25.9%	$4.35B+3.4%	$4B-2.2%
Gross profit	$10.78B+15.4%	$12.07B+12.7%	$10.47B+2.2%	$11.08B+8.0%	$9.34B+13.7%
Gross margin	71.9%+1.9pp	72.6%+1.7pp	66.4%-4.5pp	71.8%+0.9pp	70%+3.3pp
Selling, general and administrative	$3.58B+8.7%	$3.9B+1.0%	$3.57B-15.1%	$3.25B-3.7%	$3.29B-0.7%
Total costs & expenses	$11.01B+14.6%	$12.07B-27.2%	$13.87B+30.5%	$10.53B+0.6%	$9.61B+1.0%
Operating income	$3.99B+6.9%	$4.54B—	$1.9B-50.3%	$4.89B+22.4%	$3.73B+33.4%
Operating margin	26.6%-1.4pp	27.3%—	12.1%-14.4pp	31.7%+4.1pp	28%+5.2pp
Income before income taxes	$1.04B-37.4%	$2.67B—	$714M-65.7%	$1.55B-27.6%	$1.66B-5.4%
Income tax expense	$342M-8.1%	$853M+138%	$526M+1.2%	$613M-20.7%	$372M-2.9%
Net income	$695M-46.0%	$1.82B+8,355%	$186M-88.1%	$938M-31.5%	$1.29B-6.1%
Net margin	4.6%-5.0pp	10.9%+11.1pp	1.2%-9.6pp	6.1%-3.4pp	9.6%-1.5pp
Diluted earnings per share	$0.39-45.8%	$1.02+5,200%	$0.10-88.6%	$0.52-32.5%	$0.72-6.5%
Basic earnings per share	$0.39-45.8%	$1.02+5,200%	$0.10-88.6%	$0.52-32.5%	$0.72-6.5%
Weighted-average shares, diluted	1.8B+0.1%	1.8B0.0%	1.8B0.0%	1.8B0.0%	1.8B-0.1%
Weighted-average shares, basic	1.8B+0.1%	1.8B0.0%	1.8B0.0%	1.8B0.0%	1.8B-0.1%
Acquired IPR&D Expense	$744M+200%	$1.27B-19.6%	$2.68B+3,168%	$823M-12.2%	$248M+51.2%
Derivative Gain (Loss) Excluded from Effectiveness	-$645M-2.9%	-$655M-7.4%	-$667M-12.9%	-$678M-34.0%	-$627M-38.4%
Interest Income (Expense), Non-operating	-$645M-2.9%	-$655M-7.4%	-$667M-12.9%	-$678M-34.0%	-$627M-38.4%
Interest Income (Expense), Nonoperating	-$645M-2.9%	-$655M-7.4%	-$667M-12.9%	-$678M-34.0%	-$627M-38.4%
Other income, net (Note 6)	-$2.31B-59.6%	-$1.21B-707%	-$503M+56.6%	-$2.64B-96.2%	-$1.45B-147%
Research and development expense	$2.47B+19.6%	$2.58B-61.9%	$2.32B+8.9%	$2.13B+9.4%	$2.07B+6.6%
EBIT	$3.99B+6.9%	$4.54B—	$1.9B-50.3%	$4.89B+22.4%	$3.73B+33.4%
EBITDA	$5.93B+2.7%	$6.53B—	$4B-32.5%	$6.98B+14.8%	$5.77B+18.5%
EBITDA	$5.93B+2.7%	$6.53B—	$4B-32.5%	$6.98B+14.8%	$5.77B+18.5%
EBITDA margin	39.5%-3.8pp	39.3%—	25.3%-15.6pp	45.3%+3.2pp	43.3%+3.7pp
EBIT	$3.99B+6.9%	$4.54B—	$1.9B-50.3%	$4.89B+22.4%	$3.73B+33.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about AbbVie.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AbbVie's revenue?: AbbVie (ABBV) generated $62.8B in revenue over the trailing twelve months, up 9.5% year over year.
Is AbbVie profitable?: AbbVie reported $3.6B in net income over the trailing twelve months, a 5.8% net margin.
What are AbbVie's profit margins?: Gross margin is 70.7% and operating margin is 24.4%, with a 5.8% net margin.
What is AbbVie's earnings per share?: AbbVie's diluted EPS over the trailing twelve months is $2.03.
Where does AbbVie's income statement data come from?: Every line is extracted from AbbVie's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.